This research report titled ‘Global Microarray Market 2016-2020’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes an up to date analysis and forecasts for various market segments and all geographical regions.
“The increased focus on developing personalized medicines, especially in the field of oncology, will propel the demand for solutions based on microarray technologies as cancer patients require multiple and complex genetic tests to understand their specific gene patterns, which can be efficiently achieved through microarray solutions,” says Amber Chourasia, a lead analyst at Technavio for lab equipment research.
Request a sample report: http://www.technavio.com/request-a-sample?report=54593
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
The report categorizes the global microarray market into three major application segments. They are:
- Gene expression
- Disease diagnosis and expression
Global microarray market in gene expression segment
Microarrays are used in gene expression owing to their ability to measure the expression level of thousands of genes simultaneously within a particular mRNA sample. In the last few years, gene expression studies have witnessed an increase in the volume of gene expression analysis and have played an important role in the clinical diagnosis of abnormal gene expressions, thereby creating a large demand for microarray solutions. Tissue microarrays have made it easier for researchers to analyze gene expression in multiple pathological samples on a single slide due the ease of use and advanced technology.
Gene expression products have varied usage in areas such as clinical diagnostics, agriculture, and biodefense. The gene expression information generated using microarrays can be applied in medicine for clinically relevant groups to detect new subclasses of diseases and predict outcomes that are clinically important, including the response to therapy and survival.
The rapid technological advances in microarray instruments and consumables will improve the accuracy, sensitivity, reproducibility, and speed of conducting tests due to which the adoption of these solutions will increase, thereby saving time and cost for the users.
Global microarray market in disease diagnosis and drug development segment
Microarray technologies are widely used in drug discovery to determine and develop drug molecules in a short duration with high specificity. Severe chronic diseases such as cancer, mental illness, cardiac diseases, and infectious diseases can be studied by using microarray technology to analyze gene patterns. Researchers can classify different types of cancers based on the gene activity patterns in tumor cells, which helps in the design of target-specific treatments.
The key driver of microarray consumption in this segment is the need for early detection of diseases and targeted treatment options. The drug discovery and development segment involves the discovery of effective drugs for the treatment of diseases. The popularity of these solutions can be attributed to their capability of measuring expression patterns of thousands of genes simultaneously, enabling rapid identification of targets for therapeutic intervention. “In addition, microarrays help in monitoring changes in gene expression in response to drug treatments,” says Amber.
Global microarray market in others segment
The other segment includes application of microarray technology in several research fields, including toxicological research, genomics and proteomics, biomedical and clinical, agricultural biology, and pharmacogenomics. For instance, protein microarrays find extensive applications in biomarker discovery, protein interaction, and profiling of enzyme-substrates, as well as immunological profiling and vaccine development in the field of proteomics.
The other segment also comprises microarray applications in point-of-care (POC) and academic research, which are gradually increasing by the day to develop high-quality solutions. In biomedical research, DNA microarrays are used for the study of gene expression, single-nucleotide polymorphism (SNP) detection, detection of methylation patterns abnormality, and pathogen detection. In toxicology research, microarray technology is used for determining the gene expression of mRNA. Molecular mechanisms of toxicity can also be screened using microarray technology, thereby propelling the growth of the market.
The top vendors highlighted by Technavio’s research analysts in this report are:
- Agilent Technologies
- Thermo Fisher Scientific
Browse Related Reports:
- Global DNA Sequencing Products Market 2016-2020
- Global DNA Microarray Market 2016-2020
- Global Genome Engineering Market 2016-2020
Do you need a report on a market in a specific geographical cluster or country but can’t find what you’re looking for? Don’t worry, Technavio also takes client requests. Please contact firstname.lastname@example.org with your requirements and our analysts will be happy to create a customized report just for you.
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at email@example.com.